UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 417

Sortiert nach

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (36), p.13133-13138

2014

Volltextzugriff (PDF)

“Product on Stopper” in a Lyophilized Drug Product: Cosmetic Defect or a Product Quality Concern?

Journal of pharmaceutical sciences, 2018-06, Vol.107 (6), p.1736-1740

2018

Volltextzugriff (PDF)

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

Proceedings of the National Academy of Sciences - PNAS, 2020-07, Vol.117 (30), p.17957-17964

2020

Volltextzugriff (PDF)

Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination

Science (American Association for the Advancement of Science), 2020-10, Vol.370 (6513), p.237-241

2020

Volltextzugriff (PDF)

An Exploratory Study on Optimal Iterative Design Schedules with the Consideration of Design Quality and Resource Constraints

Sustainability, 2021-04, Vol.13 (8), p.4584

2021

Volltextzugriff (PDF)

Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite

Nature, 2007-11, Vol.450 (7169), p.560-565

2007

Volltextzugriff (PDF)

Revolutionizing steel building project cost overrun risk assessment by Bayesian network

Engineering, construction, and architectural management, 2023-06

2023

Volltextzugriff (PDF)

Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure

Cancer chemotherapy and pharmacology, 2014-04, Vol.73 (4), p.729-736

2014

Volltextzugriff (PDF)

1342 A novel dual CAB Nectin-4 x CD3 bispecific antibody targeting solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1496-A1496

2023

Volltextzugriff (PDF)

1343 Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1497-A1497

2023

Volltextzugriff (PDF)

Development of a pharmacist–psychiatrist collaborative medication therapy management clinic

Journal of the American Pharmacists Association, 2012, Vol.52 (6), p.e252-e258

2012

Volltextzugriff (PDF)

Ion States and Transport in Styrenesulfonate Methacrylic PEO9 Random Copolymer Ionomers

Macromolecules, 2015-10, Vol.48 (19), p.7273-7285

2015

Volltextzugriff (PDF)

Abstract 1870: Novel conditionally active bispecific T cell engagers targeting solid tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1870-1870

2021

Volltextzugriff (PDF)

Abstract 694: Novel conditionally active bispecific EpCAM x CD3 T cell engagers targeting solid tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.694-694

2021

Volltextzugriff (PDF)

Protein‐associated chemical switches differentially modulate the binding activities of human apolipoprotein E isoforms with their receptors and with amyloid beta peptides

Alzheimer's & dementia, 2021-12, Vol.17, p.e057793-n/a

2021

Volltextzugriff (PDF)

Abstract 4560: Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4560-4560

2020

Volltextzugriff (PDF)

Abstract 5698: Novel conditionally active bispecific T cell engagers targeting solid tumors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5698-5698

2020

Volltextzugriff (PDF)

The Gal4 Activation Domain Binds Sug2 Protein, a Proteasome Component, in Vivo and in Vitro

The Journal of biological chemistry, 2001-08, Vol.276 (33), p.30956-30963

2001

Volltextzugriff (PDF)

Monoclonal antibodies recognizing the Enterococcus faecalis collagen-binding MSCRAMM Ace: Conditional expression and binding analysis

Microbial pathogenesis, 2007-08, Vol.43 (2), p.55-66

2007

Volltextzugriff (PDF)

Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans

Journal of virology, 2018-07, Vol.92 (14)

2018

Volltextzugriff (PDF)

Abstract 2708: Potent CAB CTLA4 antibody to reduce immune side effects and toxicities associated with single-agent and combination cancer immuno therapies

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2708-2708

2019

Volltextzugriff (PDF)

Abstract 356: Novel conditionally active biologic (CAB) antibody targeting EpCAM demonstrates anti-tumor efficacy in vivo

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.356-356

2019

Volltextzugriff (PDF)

Identifying Spatial Driving Factors of Energy and Water Consumption in the Context of Urban Transformation

Sustainability, 2021-10, Vol.13 (19), p.10503

2021

Volltextzugriff (PDF)

Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.827-827

2018

Volltextzugriff (PDF)

Abstract 833: Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.833-833

2018

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(386)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(246)
Life Sciences & Biomedicine
(211)
Humans
(177)
Female
(105)
Male
(100)
Middle Aged
(64)
Oncology
(63)
Adult
(62)
Aged
(52)
Biological And Medical Sciences
(46)
Medical Sciences
(38)
Animals
(30)
General & Internal Medicine
(24)
Medicine, General & Internal
(24)
Patients
(23)
Aged, 80 And Over
(22)
Treatment Outcome
(22)
Medicine
(21)
Risk Factors
(21)
Science & Technology - Other Topics
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

“Product on Stopper” in a Lyophilized Drug Product: Cosmetic Defect or a Product Quality Concern?

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination

An Exploratory Study on Optimal Iterative Design Schedules with the Consideration of Design Quality and Resource Constraints

Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite

Revolutionizing steel building project cost overrun risk assessment by Bayesian network

Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure

1342 A novel dual CAB Nectin-4 x CD3 bispecific antibody targeting solid tumors

1343 Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors

Development of a pharmacist–psychiatrist collaborative medication therapy management clinic

Ion States and Transport in Styrenesulfonate Methacrylic PEO9 Random Copolymer Ionomers

Abstract 1870: Novel conditionally active bispecific T cell engagers targeting solid tumors

Abstract 694: Novel conditionally active bispecific EpCAM x CD3 T cell engagers targeting solid tumors

Protein‐associated chemical switches differentially modulate the binding activities of human apolipoprotein E isoforms with their receptors and with amyloid beta peptides

Abstract 4560: Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors

Abstract 5698: Novel conditionally active bispecific T cell engagers targeting solid tumors

The Gal4 Activation Domain Binds Sug2 Protein, a Proteasome Component, in Vivo and in Vitro

Monoclonal antibodies recognizing the Enterococcus faecalis collagen-binding MSCRAMM Ace: Conditional expression and binding analysis

Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans

Abstract 2708: Potent CAB CTLA4 antibody to reduce immune side effects and toxicities associated with single-agent and combination cancer immuno therapies

Abstract 356: Novel conditionally active biologic (CAB) antibody targeting EpCAM demonstrates anti-tumor efficacy in vivo

Identifying Spatial Driving Factors of Energy and Water Consumption in the Context of Urban Transformation

Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC

Abstract 833: Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC

Suchergebnisse filtern